FDA Declines to Review Moderna’s mRNA Flu Vaccine Application THURSDAY, Feb. 12, 2025 (HealthDay News) — In a major blow to vaccine development, the U.S. Food and Drug Administration (FDA) said it will not review Moderna’s application for the first mRNA-based flu shot. Full Article
